Pharmaceutical sciences

Pharmacogenomics and medicines optimisation to be one of eight NHS ‘genomic networks of excellence’

The network will focus on developing the rollout of pharmacogenomics and medicines optimisation in the NHS, including in primary care to address adverse drug reactions.…

Widespread pharmacogenomic testing in psychiatry needs a stronger evidence base

More research into the genomic factors influencing psychiatric medicines response is needed before widespread pharmacogenomic testing can be justified.…

Expanded genetic profiling could guide cancer treatment, study finds

Researchers analysed whole-genome data with data from the NHS, revealing genetic changes in cancers that may affect survival rates and patient outcomes.…

Supporting an early-career researcher in uncovering the barriers to wider pharmacy research

The Pharmacy Research Advisory Group shares how it supported a clinical Fellow in finding out why research is not a core function of all clinical pharmacists’ roles.…

Rheumatoid arthritis: management

An overview of the medicines used for symptom control and disease modification, with consideration given to non-pharmacological approaches that support management of rheumatoid arthritis.…

Geraldine McCaffrey: ‘The advances we’re making in Wales are really exciting’

The recently elected chair of the Royal Pharmaceutical Society’s Welsh Pharmacy Board talks to The Pharmaceutical Journal about the Society’s role in assisting the evolving workforce in Wales.…

Nominations are open for upcoming 100-year anniversary of the Harrison Medal

In 2024, it will mark exactly 100 years since the Harrison Medal was first awarded by the Royal Pharmaceutical Society (RPS) to recognise an individual’s outstanding contributions to advancing pharmaceutical science. The award was set up in memory of Lieutenant-Colonel Edward Frank Harrison (1869�…

How to develop a new clinical service

Delivery of the ‘NHS long-term plan’ requires the development of innovative new services. This article outlines how a new clinical service can be developed sharing learnings from the development of a paediatric ambulatory care service.…

BTK inhibitors: what pharmacists need to know

In this episode of The PJ Pod, we consider the impact bruton tyrosine kinase (BTK) inhibitors have had on care for patients with B-cell malignancies and explore how pharmacists can help patients get the best out of their treatment regimens.…

Supported content

NHS England to commission evaluation of community pharmacy clinical services

The evaluation will be used to help NHS England “make effective decisions regarding clinical services for the future community pharmacy sector”.…